468 related articles for article (PubMed ID: 25465297)
1. Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.
Shamseddine AA; Airola MV; Hannun YA
Adv Biol Regul; 2015 Jan; 57():24-41. PubMed ID: 25465297
[TBL] [Abstract][Full Text] [Related]
2. Neutral sphingomyelinase and breast cancer research.
Hwang SY; Kim TH; Lee HH
J Menopausal Med; 2015 Apr; 21(1):24-7. PubMed ID: 26046034
[TBL] [Abstract][Full Text] [Related]
3. Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD).
Wang G; Dinkins M; He Q; Zhu G; Poirier C; Campbell A; Mayer-Proschel M; Bieberich E
J Biol Chem; 2012 Jun; 287(25):21384-95. PubMed ID: 22532571
[TBL] [Abstract][Full Text] [Related]
4. Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.
Wu BX; Clarke CJ; Hannun YA
Neuromolecular Med; 2010 Dec; 12(4):320-30. PubMed ID: 20552297
[TBL] [Abstract][Full Text] [Related]
5. Neutral sphingomyelinases and nSMase2: bridging the gaps.
Clarke CJ; Hannun YA
Biochim Biophys Acta; 2006 Dec; 1758(12):1893-901. PubMed ID: 16938269
[TBL] [Abstract][Full Text] [Related]
6. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.
Cinq-Frais C; Coatrieux C; Grazide MH; Hannun YA; Nègre-Salvayre A; Salvayre R; Augé N
Biochim Biophys Acta; 2013 Aug; 1831(8):1344-56. PubMed ID: 23651497
[TBL] [Abstract][Full Text] [Related]
7. Exosomal neutral sphingomyelinase 1 suppresses hepatocellular carcinoma via decreasing the ratio of sphingomyelin/ceramide.
Lin M; Liao W; Dong M; Zhu R; Xiao J; Sun T; Chen Z; Wu B; Jin J
FEBS J; 2018 Oct; 285(20):3835-3848. PubMed ID: 30106227
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway.
Lee JT; Xu J; Lee JM; Ku G; Han X; Yang DI; Chen S; Hsu CY
J Cell Biol; 2004 Jan; 164(1):123-31. PubMed ID: 14709545
[TBL] [Abstract][Full Text] [Related]
9. Neutral Sphingomyelinases in Cancer: Friend or Foe?
Clarke CJ
Adv Cancer Res; 2018; 140():97-119. PubMed ID: 30060818
[TBL] [Abstract][Full Text] [Related]
10. Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis.
Zhang P; Liu B; Jenkins GM; Hannun YA; Obeid LM
J Biol Chem; 1997 Apr; 272(15):9609-12. PubMed ID: 9092485
[TBL] [Abstract][Full Text] [Related]
11. Implication of sphingomyelin/ceramide molar ratio on the biological activity of sphingomyelinase.
Boulgaropoulos B; Amenitsch H; Laggner P; Pabst G
Biophys J; 2010 Jul; 99(2):499-506. PubMed ID: 20643068
[TBL] [Abstract][Full Text] [Related]
12. Interaction of Synaptosomal-Associated Protein 25 with Neutral Sphingomyelinase 2: Functional Impact on the Sphingomyelin Pathway.
Won JH; Jeon HJ; Kim SK; Shin IC; Jang JM; Ha HC; Back MJ; Kim DK
Neuroscience; 2020 Feb; 427():1-15. PubMed ID: 31765623
[TBL] [Abstract][Full Text] [Related]
13. Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha.
Gerritsen ME; Shen CP; Perry CA
Am J Pathol; 1998 Feb; 152(2):505-12. PubMed ID: 9466577
[TBL] [Abstract][Full Text] [Related]
14. Identification and evaluation of neutral sphingomyelinase 2 inhibitors.
Lee DH; Kim SH; Ahn KH; Kim SK; Choi JM; Ji JE; Won JH; Park YH; Lim C; Kim S; Kim DK
Arch Pharm Res; 2011 Feb; 34(2):229-36. PubMed ID: 21380806
[TBL] [Abstract][Full Text] [Related]
15. The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activity.
Qin J; Kilkus J; Dawson G
Biochim Biophys Acta; 2016 Feb; 1861(2):78-90. PubMed ID: 26548718
[TBL] [Abstract][Full Text] [Related]
16. [Advance in research on regulatory mechanism and functions of neutral sphingomyelinse 2].
Zhang L; Guo J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Oct; 35(5):581-5. PubMed ID: 24183051
[TBL] [Abstract][Full Text] [Related]
17. Curcumin induces apoptosis of multidrug-resistant human leukemia HL60 cells by complex pathways leading to ceramide accumulation.
Shakor AB; Atia M; Ismail IA; Alshehri A; El-Refaey H; Kwiatkowska K; Sobota A
Biochim Biophys Acta; 2014 Dec; 1841(12):1672-82. PubMed ID: 25240837
[TBL] [Abstract][Full Text] [Related]
18. [Study of sphingomyelinase activity and sphingomyelin and ceramide levels in comparison with other lipid fractions of the cell nucleus in regenerating rat liver].
Pushkarev MIu; Borovkova OV; Alesenko AV
Biokhimiia; 1991 May; 56(5):903-12. PubMed ID: 1747416
[TBL] [Abstract][Full Text] [Related]
19. Sphingomyelinases and Liver Diseases.
Insausti-Urkia N; Solsona-Vilarrasa E; Garcia-Ruiz C; Fernandez-Checa JC
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143193
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan synthase-2 upregulation protects smpd3-deficient fibroblasts against cell death induced by nutrient deprivation, but not against apoptosis evoked by oxidized LDL.
Garoby-Salom S; Rouahi M; Mucher E; Auge N; Salvayre R; Negre-Salvayre A
Redox Biol; 2015; 4():118-26. PubMed ID: 25555205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]